Approach to Perineal Lymphadenopathy
Perineal lymphadenopathy requires immediate systematic evaluation beginning with fine-needle aspiration (FNA) for any node >1 cm, while simultaneously conducting a focused search for primary lesions in the drainage basin—including the perineum, genitalia, anus, and lower extremities—because 70% of palpable inguinal nodes harbor malignancy in adults, though infectious causes predominate in children. 1, 2, 3
Initial Clinical Assessment
Determine if lymphadenopathy is localized or generalized, as this fundamentally changes your differential diagnosis and workup strategy. 4, 3
Critical History Elements
- Duration of lymphadenopathy – nodes persisting >4 weeks require imaging and laboratory workup regardless of other features 3, 5
- Constitutional symptoms – fever, night sweats, unintentional weight loss suggest malignancy or systemic disease 3, 5
- Age and sex – males >40 years with white race have higher malignancy risk 5
- Sexual history – in sexually active adolescents/adults, consider STIs including lymphogranuloma venereum, HSV, or syphilis 6
- Recent trauma or infection – examine for cuts, abrasions, insect bites, cellulitis, or fungal infections of lower extremities 6
Physical Examination Priorities
Examine the entire lymphatic drainage basin systematically: 4, 7
- Perineum and genitalia – look for ulcers, warts, condylomata, herpes lesions, or masses 4, 7
- Anus and rectum – perform anogenital examination for rectal cancer, anal lesions, or STDs 4
- Lower extremities bilaterally – inspect for skin lesions, melanoma, or infection sources 6
- Contralateral groin – crossover lymphatic drainage occurs, making bilateral assessment mandatory 2, 8
Document node characteristics precisely: 2
- Size (nodes >2 cm are concerning for malignancy) 3
- Number of nodes
- Unilateral vs bilateral
- Mobility vs fixation to skin or deeper structures
- Tenderness
- Overlying skin changes (erythema, ulceration)
Diagnostic Algorithm by Clinical Scenario
For Adults with Palpable Inguinal/Perineal Nodes
Proceed directly to FNA as the mandatory first diagnostic step – sensitivity 91.7%, specificity 98.2% for malignancy detection. 1 Do not delay with empiric antibiotics unless there is clear evidence of acute bacterial infection (rapid onset, fever, erythema, tenderness). 1, 5
If FNA is negative but node characteristics are concerning (heterogeneous on imaging, hard, matted, >2 cm), confirm with excisional biopsy because FNA can miss malignancy. 1, 3
If FNA is positive for malignancy, proceed immediately to disease-specific oncologic management:
- Penile cancer → immediate inguinal lymph node dissection (ILND) 1, 2
- Melanoma → wide excision and sentinel node mapping 1
- Lymphoma → core needle or excisional biopsy for full histologic classification 1
For Children with Inguinal/Perineal Lymphadenopathy
Search systematically for infection sources before considering biopsy: 6
- Inspect ipsilateral lower extremity – cuts, abrasions, insect bites, cellulitis, tinea pedis 6
- Examine perineal/genital/perianal region – diaper dermatitis, trauma, lesions 6
- Consider STIs only if appropriate – genital ulcers or concerning social history in adolescents 6
For small, mobile, tender nodes without systemic symptoms – observe with clinical reassessment in 2-4 weeks. 6 Nodes should decrease in size within 4-6 weeks; lack of improvement mandates escalation. 6
Avoid empiric antibiotics when viral prodrome or minor local infection is identified – observation alone is appropriate. 6
If biopsy is needed in children, excisional biopsy is preferred over FNA when malignancy or granulomatous disease (including nontuberculous mycobacteria) is suspected. 6
Laboratory and Imaging Workup
Obtain when lymphadenopathy persists >4 weeks or systemic symptoms are present: 3, 5
- Complete blood count with differential 3
- C-reactive protein and erythrocyte sedimentation rate 3
- Tuberculosis testing (PPD or IGRA) 3
- HIV testing in appropriate clinical contexts 4, 7
Imaging modalities by indication: 2, 8
- Ultrasound – first-line for characterizing node architecture and guiding FNA 8
- CT or MRI – for palpable disease to assess size, extent, relationship to structures, and pelvic/retroperitoneal involvement 2
- PET/CT – sensitivity 88%, specificity 98%, but cannot distinguish inflammation from metastasis and has limited resolution <10 mm 8
- MRI – best single modality for evaluating primary lesion and lymph node status when physical exam is difficult 2
Critical Differential Diagnoses
Malignant Etiologies (Require Urgent Evaluation)
- Penile squamous cell carcinoma – inguinal nodes are the most frequent metastatic site; 70% of palpable nodes harbor malignancy 2
- Melanoma of lower extremity – popliteal and inguinal nodes are abnormal when palpable 5
- Vulvar/anal cancer – drain to inguinal and pelvic nodes 1
- Lymphoma – requires excisional biopsy, not FNA alone, for definitive diagnosis 1
Infectious/Inflammatory Causes
- Reactive lymphadenopathy – 30-50% of palpable inguinal nodes are inflammatory, not malignant 1, 2
- Bacterial lymphadenitis – Staphylococcus aureus or Streptococcus pyogenes with rapid onset, fever, tenderness 6
- STIs – lymphogranuloma venereum, HSV, syphilis in sexually active patients 6
- Nontuberculous mycobacteria – rare in inguinal region but consider in immunocompromised 9
Common Pitfalls to Avoid
Do not assume all palpable lymphadenopathy is malignant – 30-50% of cases are inflammatory, but do not delay FNA in adults with concerning features. 1, 2
Do not proceed to immediate surgical excision without FNA in adults – this leads to unnecessary morbidity and delays diagnosis. 1
Do not use corticosteroids empirically – they mask histologic diagnosis of lymphoma and other malignancies. 3, 5
Do not forget to examine the contralateral groin – crossover lymphatic drainage occurs through presymphyseal lymphatics. 8, 2
In children, do not overlook minor skin infections – small cuts or fungal infections between toes commonly cause reactive inguinal nodes. 6
Follow-Up Strategy
If confirmed reactive lymphadenopathy: 1
- Address underlying cause (treat infection, remove irritant)
- Monitor node size and characteristics at 2-4 week intervals
- Consider repeat biopsy if node enlarges or develops concerning features
If malignancy is confirmed: 1
- Follow disease-specific oncologic protocols
- Repeat imaging to assess treatment response
- For penile cancer with positive nodes, consider adjuvant chemotherapy if extranodal extension is present 2